These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29075792)

  • 41. Meal intake increases circulating procoagulant microparticles in patients with type 1 and type 2 diabetes mellitus.
    Spectre G; Mobarrez F; Stålesen R; Östenson CG; Varon D; Wallen H; Hjemdahl P
    Platelets; 2019; 30(3):348-355. PubMed ID: 29547014
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Protein S and factor V in regulation of coagulation on platelet microparticles by activated protein C.
    Somajo S; Koshiar RL; Norström E; Dahlbäck B
    Thromb Res; 2014 Jul; 134(1):144-52. PubMed ID: 24835672
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Coagulation activation and microparticle-associated coagulant activity in cancer patients. An exploratory prospective study.
    van Doormaal F; Kleinjan A; Berckmans RJ; Mackman N; Manly D; Kamphuisen PW; Richel DJ; Büller HR; Sturk A; Nieuwland R
    Thromb Haemost; 2012 Jul; 108(1):160-5. PubMed ID: 22535219
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Circulating platelet-derived microparticles in systemic lupus erythematosus. Association with increased thrombin generation and procoagulant state.
    Pereira J; Alfaro G; Goycoolea M; Quiroga T; Ocqueteau M; Massardo L; Pérez C; Sáez C; Panes O; Matus V; Mezzano D
    Thromb Haemost; 2006 Jan; 95(1):94-9. PubMed ID: 16543967
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intercellular transfer of tissue factor via the uptake of tumor-derived microvesicles.
    Lima LG; Leal AC; Vargas G; Porto-Carreiro I; Monteiro RQ
    Thromb Res; 2013 Oct; 132(4):450-6. PubMed ID: 23993901
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Formation of procoagulant microparticles and properties.
    Freyssinet JM; Toti F
    Thromb Res; 2010 Apr; 125 Suppl 1():S46-8. PubMed ID: 20153515
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Microparticles (MPs), tissue factor (TF) and tissue factor inhibitor (TFPI) in cord blood plasma. A preliminary study and literature survey of procoagulant properties of MPs.
    Uszyński M; Zekanowska E; Uszyński W; Kuczyński J; Zyliński A
    Eur J Obstet Gynecol Reprod Biol; 2011 Sep; 158(1):37-41. PubMed ID: 21664032
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Physiopathological significance of catalytic phospholipids in the generation of thrombin.
    Dachary-Prigent J; Toti F; Satta N; Pasquet JM; Uzan A; Freyssinet JM
    Semin Thromb Hemost; 1996; 22(2):157-64. PubMed ID: 8807713
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Evaluation of the procoagulant activity of endogenous phospholipids in the platelet-free plasma of children with sickle cell disease using functional assays.
    Noubouossie DC; Lê PQ; Rozen L; Debaugnies F; Ferster A; Demulder A
    Thromb Res; 2012 Aug; 130(2):259-64. PubMed ID: 22079446
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cell-derived microparticles generated in patients during cardiopulmonary bypass are highly procoagulant.
    Nieuwland R; Berckmans RJ; Rotteveel-Eijkman RC; Maquelin KN; Roozendaal KJ; Jansen PG; ten Have K; Eijsman L; Hack CE; Sturk A
    Circulation; 1997 Nov; 96(10):3534-41. PubMed ID: 9396452
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Correlation between platelet-derived microparticle enumeration by flow cytometry and phospholipid-dependent procoagulant activity in microparticles: the centrifugation step matters!
    Stagnara J; Garnache Ottou F; Angelot F; Mourey G; Seilles E; Biichlé S; Saas P; Racadot E
    Thromb Haemost; 2012 Jun; 107(6):1185-7. PubMed ID: 22476436
    [No Abstract]   [Full Text] [Related]  

  • 52. Modelization of Blood-Borne Hypercoagulability in Myeloma: A Tissue-Factor-Bearing Microparticle-Driven Process.
    Papageorgiou L; Alhaj Hussen K; Thouroude S; Mbemba E; Cost H; Garderet L; Elalamy I; Larsen A; Van Dreden P; Dimopoulos MA; Mohty M; Gerotziafas GT
    TH Open; 2019 Oct; 3(4):e340-e347. PubMed ID: 31693008
    [No Abstract]   [Full Text] [Related]  

  • 53. Prognostic implications and procoagulant activity of phosphatidylserine exposure of blood cells and microparticles in patients with atrial fibrillation treated with pulmonary vein isolation.
    Meng H; Kou J; Ma R; Ding W; Kou Y; Cao M; Dong Z; Bi Y; Thatte HS; Shi J
    Mol Med Rep; 2017 Dec; 16(6):8579-8588. PubMed ID: 29039531
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Procoagulant activity, but not number, of microparticles increases with age and in individuals after a single venous thromboembolism.
    Owen BA; Xue A; Heit JA; Owen WG
    Thromb Res; 2011 Jan; 127(1):39-46. PubMed ID: 21106230
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation.
    Berckmans RJ; Nieuwland R; Böing AN; Romijn FP; Hack CE; Sturk A
    Thromb Haemost; 2001 Apr; 85(4):639-46. PubMed ID: 11341498
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of the procoagulant activity in the plasma of cancer patients using a thrombin generation assay.
    Debaugnies F; Azerad MA; Noubouossié D; Rozen L; Hemker HC; Corazza F; Efira A; Demulder A
    Thromb Res; 2010 Dec; 126(6):531-5. PubMed ID: 20870277
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Circulating erythrocyte-derived microparticles are associated with coagulation activation in sickle cell disease.
    van Beers EJ; Schaap MC; Berckmans RJ; Nieuwland R; Sturk A; van Doormaal FF; Meijers JC; Biemond BJ;
    Haematologica; 2009 Nov; 94(11):1513-9. PubMed ID: 19815831
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Circulating tissue factor procoagulant activity and thrombin generation in patients with type 2 diabetes: effects of insulin and glucose.
    Boden G; Vaidyula VR; Homko C; Cheung P; Rao AK
    J Clin Endocrinol Metab; 2007 Nov; 92(11):4352-8. PubMed ID: 17785358
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Tissue factor positive microparticles as a biomarker for increased risk of breast cancer-associated thrombosis: a mini review.
    Bucciol R; Othman M
    Curr Opin Hematol; 2023 Sep; 30(5):180-185. PubMed ID: 37522480
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Microparticles: a link to increased thrombin generation.
    Gasa N; Meiring M
    Blood Coagul Fibrinolysis; 2021 Apr; 32(3):204-208. PubMed ID: 33560006
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.